The aims of the current retrospective study were to investigate the clinical implications of elevated serum IL-6 in IgG4-RD patients, and to examine whether IL-6 can predict the activity and/or relapse of the disease. The gene discussed is IL6; the disease is immunoglobulin G4-related sclerosing disease.